ddms has been researched along with arachidonic acid in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (90.91) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beilin, LJ; Chu, ZM; Croft, KD; Falck, JR; Kingsbury, DA; Reddy, KM | 1 |
| Baum, M; Falck, JR; Griener, JC; Quigley, R; Reddy, KM | 1 |
| Brand-Schieber, E; Falck, JF; Schwartzman, M | 1 |
| Carroll, MA; Falck, JR; McGiff, JC; Pomposiello, SI | 1 |
| Alonso-Galicia, M; Cowley, AW; Greene, AS; Maier, KG; Roman, RJ | 1 |
| Gu, RM; Wang, WH | 1 |
| Falck, JR; Gopal, VR; Kaide, J; Laniado-Schwartzman, M; Nasjletti, A; Wang, JS; Wang, MH; Zhang, F | 1 |
| Deng, H; Falck, JR; Gopal, VR; Kemp, R; Laniado-Schwartzman, M; Nasjletti, A; Singh, H; Zhang, F | 1 |
| Campbell, WB; Endsley, MP; Falck, JR; Gross, GJ; Isbell, MA; Moore, JM; Nithipatikom, K | 1 |
| Falck, JR; Gross, GJ; Isbell, MA; Moore, JM; Nithipatikom, K | 1 |
| Berthiaume, M; Corriveau, S; Pasquier, JC; Rousseau, E | 1 |
11 other study(ies) available for ddms and arachidonic acid
| Article | Year |
|---|---|
Cytochrome P450 metabolites of arachidonic acid may be important mediators in angiotensin II-induced vasoconstriction in the rat mesentery in vivo.
Topics: Amides; Angiotensin II; Animals; Arachidonic Acid; Area Under Curve; Carotid Arteries; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; Female; Hydroxyeicosatetraenoic Acids; Mesenteric Arteries; Miconazole; Microsomes; Norepinephrine; Perfusion; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sulfones; Vasoconstriction | 2000 |
Effects of 20-HETE and 19(S)-HETE on rabbit proximal straight tubule volume transport.
Topics: Amides; Animals; Arachidonic Acid; Biological Transport, Active; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Kidney Tubules, Proximal; Mixed Function Oxygenases; Perfusion; Rabbits; Sodium-Potassium-Exchanging ATPase; Sulfones | 2000 |
Selective inhibition of arachidonic acid epoxidation in vivo.
Topics: 8,11,14-Eicosatrienoic Acid; Amides; Animals; Arachidonic Acid; Chromatography, High Pressure Liquid; Cyclodextrins; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fatty Acids, Unsaturated; Humans; Immunoblotting; Kidney; Male; Miconazole; Microsomes; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Sulfones | 2000 |
Epoxyeicosatrienoic acid-mediated renal vasodilation to arachidonic acid is enhanced in SHR.
Topics: 5,8,11,14-Eicosatetraynoic Acid; 8,11,14-Eicosatrienoic Acid; Acetylcholine; Amides; Animals; Arachidonic Acid; Enzyme Inhibitors; Hypertension; Indomethacin; Male; Nitroprusside; Perfusion; Pressure; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Renal Circulation; Sulfones; Tin Compounds; Vasodilation | 2001 |
Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II.
Topics: Amides; Angiotensin II; Animals; Arachidonic Acid; Blood Pressure; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Hydroxyeicosatetraenoic Acids; Hypertension; Kidney; Male; Mixed Function Oxygenases; Rats; Rats, Sprague-Dawley; Renal Circulation; Sulfones; Triazoles; Vasoconstriction; Vasoconstrictor Agents | 2002 |
Arachidonic acid inhibits K channels in basolateral membrane of the thick ascending limb.
Topics: Amides; Animals; Arachidonic Acid; Cell Membrane; Cyclooxygenase Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Female; Hydroxyeicosatetraenoic Acids; Indomethacin; Loop of Henle; Male; Membrane Potentials; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Inwardly Rectifying; Rats; Rats, Sprague-Dawley; Sulfones | 2002 |
Transfection of CYP4A1 cDNA increases vascular reactivity in renal interlobar arteries.
Topics: Amides; Animals; Arachidonic Acid; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; DNA, Complementary; Gene Expression; Hydroxyeicosatetraenoic Acids; Microcirculation; Phenylephrine; Rats; Rats, Sprague-Dawley; Renal Artery; Renal Circulation; Sulfones; Transfection; Vasoconstrictor Agents | 2003 |
Decreased levels of cytochrome P450 2E1-derived eicosanoids sensitize renal arteries to constrictor agonists in spontaneously hypertensive rats.
Topics: Amides; Animals; Arachidonic Acid; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP4A; Hydroxyeicosatetraenoic Acids; Hypertension; Phenylephrine; Potassium Channel Blockers; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Artery; Sulfones; Tetraethylammonium; Vasoconstriction; Vasoconstrictor Agents; Vasopressins | 2005 |
Effects of selective inhibition of cytochrome P-450 omega-hydroxylases and ischemic preconditioning in myocardial protection.
Topics: Amides; Animals; Arachidonic Acid; Cardiotonic Agents; Coronary Circulation; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dogs; Female; Hemodynamics; Hydroxyeicosatetraenoic Acids; Ischemic Preconditioning, Myocardial; Male; Mixed Function Oxygenases; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Sulfones | 2006 |
Epoxyeicosatrienoic acids in cardioprotection: ischemic versus reperfusion injury.
Topics: 8,11,14-Eicosatrienoic Acid; Amides; Animals; Arachidonic Acid; Cardiotonic Agents; Coronary Circulation; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dogs; Enzyme Inhibitors; Hemodynamics; Hydroxyeicosatetraenoic Acids; Mixed Function Oxygenases; Myocardial Ischemia; Myocardial Reperfusion Injury; Spectrometry, Mass, Electrospray Ionization; Sulfones | 2006 |
Inhibition of epoxy-eicosanoid degradation improves the tocolytic effects of indomethacin in the uterus from pregnant women.
Topics: Adamantane; Adult; Amides; Arachidonic Acid; Cesarean Section; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Synergism; Eicosanoids; Epoxide Hydrolases; Female; Humans; Indomethacin; Infant, Newborn; Lauric Acids; Myometrium; Pregnancy; Signal Transduction; Sulfones; Tocolytic Agents; Uterine Contraction; Young Adult | 2011 |